DIN 02254522 — APO-QUININE 300 MG
APO-QUININE is a capsule of Quinine marketed by APOTEX INC. The full Quinine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02254522
- Brand name
- APO-QUININE
- Active ingredient
- Quinine
- Strength
- 300 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- APOTEX INC
- Health Canada status
- DORMANT
- Drug class
- Antimalarial agent (cinchona alkaloid)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Quinine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02254514 | APO-QUININE | 200 MG | CAPSULE | APOTEX INC | DORMANT |
| 02445190 | JAMP QUININE | 200 MG | CAPSULE | JAMP PHARMA CORPORATION | DORMANT |
| 02445204 | JAMP QUININE | 300 MG | CAPSULE | JAMP PHARMA CORPORATION | DORMANT |
| 02311216 | PRO-QUININE - 200 | 200 MG | CAPSULE | PRO DOC LIMITEE | MARKETED |
| 02311224 | PRO-QUININE - 300 | 300 MG | CAPSULE | PRO DOC LIMITEE | MARKETED |
| 00695440 | QUININE - ODAN | 200 MG | CAPSULE | ODAN LABORATORIESLTD | DORMANT |
| 00695432 | QUININE - ODAN | 300 MG | TABLET | ODAN LABORATORIESLTD | DORMANT |
| 00695459 | QUININE - ODAN | 300 MG | CAPSULE | ODAN LABORATORIESLTD | DORMANT |
| 00021008 | TEVA-QUININE | 200 MG | CAPSULE | TEVA CANADA LIMITED | MARKETED |
| 00021016 | TEVA-QUININE | 300 MG | CAPSULE | TEVA CANADA LIMITED | MARKETED |